Medical News

RSS

Seven new nCounter PanCancer profiles launched to deeply probe cancer biology

NanoString Technologies, Inc.a provider of life science tools for translational research and molecular diagnostic products, today announced the expansion of its 3D Biology™ portfolio with the commercial launch of the nCounter® PanCancer Profiles, seven new gene expression panels each designed to interrogate a focused area of cancer biology including immuno-oncology.

9 Nov 2015

First male puberty timing study conducted

In the largest genomic analysis of puberty timing in men, new research conducted by scientists at the University of Cambridge and 23andMe* shows that the timing of puberty in males and females is influenced by many of the same-shared genetic factors. The study results are the first to quantify the strongly shared genetic basis for puberty timing between the sexes.

9 Nov 2015

Study explores prevalence of myocardial scars in middle-aged and older population

In a multiethnic, middle-aged and older study population, the prevalence of myocardial scars (evidence of a heart attack) was nearly 8 percent, of which nearly 80 percent were unrecognized by electrocardiography or clinical evaluation, according to a study in the November 10 issue of JAMA.

9 Nov 2015

Key part of MRSA vaccine puzzle unearthed

Immunologists from Trinity College Dublin have unearthed a key piece of the MRSA vaccine puzzle by identifying specific ‘helper’ cells whose role in the immune response is critical in affecting infection outcomes.

9 Nov 2015

No progression in joint damage in 84% of psoriatic arthritis patients

Novartis announced today new results for Cosentyx® (secukinumab) showing no further progression in joint damage in 84% of patients with psoriatic arthritis (PsA). In addition, Cosentyx maintained a treatment response in joint and skin disease, physical function and quality of life in patients over two years of treatment. These results from the extension phase of the FUTURE 1 study were presented at the 2015 Annual Meeting of the American College of Rheumatology (ACR) in San Francisco, United States.

9 Nov 2015

Heart attack patients diagnosed and treated for diabetes experience improved cardiac outcomes

People with heart problems often have diabetes, which puts them at greater risk for heart attacks, heart failure and stroke. Now, a new study has found that ensuring heart attack patients are promptly diagnosed and treated for diabetes makes a significant difference in improving their cardiac outcomes.

9 Nov 2015

Energy drink consumption linked with serious cardiovascular events

Anna Svatikova, M.D., Ph.D., of the Mayo Clinic, Rochester, Minn., and colleagues randomly assigned 25 healthy volunteers (age 18 years or older) to consume a can (480 mL; 16 fl. oz.) of a commercially available energy drink (Rockstar; Rockstar Inc) and placebo drink within 5 minutes, in random order on 2 separate days, maximum 2 weeks apart.

9 Nov 2015

Diabetes drug liraglutide ineffective in patients with advanced heart failure

In an attempt to correct defects in the energy generation that contributes to poor pump function among heart failure patients, researchers examined whether the diabetes drug liraglutide, could improve the condition of patients with advanced heart failure. Despite improvements in blood sugar control, the therapy did not improve the clinical stability or pumping action of the heart in patients with advanced heart failure.

9 Nov 2015

Simple, low risk blood test can detect foetal blood group and genetic conditions in unborn babies

Research into a simple, accurate and low risk blood test that can detect foetal blood group, sex, and genetic conditions in unborn babies has been published in the international scientific journal, Clinical Chemistry.

9 Nov 2015

Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients

Novartis announced today late-breaking two year results for Cosentyx® (secukinumab) showing up to 80% of patients with ankylosing spondylitis (AS) had no radiographic progression in the spine on x-ray assessment. This is the first time that data on structural spinal progression in AS have been presented for an interleukin-17A (IL-17A) inhibitor.

9 Nov 2015

Major US healthcare database has missing pieces

A major source of American health information data contains a handful of glaring flaws related to health risks, say Johns Hopkins researchers in a study published online Wednesday in the journal PLOS ONE.

9 Nov 2015

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

St. Michael's Hospital study finds that cholesterol-reducing diet also lowers blood pressure

A diet developed for reducing cholesterol also lowers blood pressure, a St. Michael's Hospital study has found.

9 Nov 2015

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Scientists from Nanyang Technological University have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively.

9 Nov 2015

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

Chromatrap, a business unit of Porvair Sciences Ltd, has announced the launch of its own range of Chromatin Immunoprecipitation (ChIP)-validated antibodies.

From Chromatrap® - Porvair Sciences Ltd 9 Nov 2015

Combatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy

Inhaled anesthetics are fairly common all over the world for minor and extensive surgical procedures in patients of all age groups. In the olden days when anesthesia was first developed, ether was the first inhaled anesthetic. That has been replaced, with the more recent discoveries of sevoflurane, isoflurane, and desflurane.

9 Nov 2015

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled “How Can I Build a Microscopy System for Optogenetics?” led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).

9 Nov 2015

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Digital Surgical Simulator Touch Surgery Collaborates with Experts Surgeons at International Institutions (Stanford, Yale, Dartmouth, Vanderbilt, Imperial College London, Singapore National Eye Center & Others) to Create Simulations of Surgical Best Practices.

6 Nov 2015

$Ixazomib’s phase 3 study in relapsed/refractory multiple myeloma presented$

Ixazomib’s phase 3 study in relapsed/refractory multiple myeloma presented

Takeda Pharmaceutical Company Limited today announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015.

6 Nov 2015

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

The capabilities of the OPMI® PENTERO® 800 surgical microscopes from ZEISS for reconstructive surgery have been enhanced by the introduction of the INFRARED 800 module.

From ZEISS Microscopy GmbH 6 Nov 2015

Medical News

Seven new nCounter PanCancer profiles launched to deeply probe cancer biology

First male puberty timing study conducted

Study explores prevalence of myocardial scars in middle-aged and older population

Key part of MRSA vaccine puzzle unearthed

No progression in joint damage in 84% of psoriatic arthritis patients

Heart attack patients diagnosed and treated for diabetes experience improved cardiac outcomes

Energy drink consumption linked with serious cardiovascular events

Diabetes drug liraglutide ineffective in patients with advanced heart failure

Simple, low risk blood test can detect foetal blood group and genetic conditions in unborn babies

Novartis’ Cosentyx® show no progression in spinal damage in 80% of ankylosing spondylitis patients

Major US healthcare database has missing pieces

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

St. Michael's Hospital study finds that cholesterol-reducing diet also lowers blood pressure

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Chromatin Immunoprecipitation validated antibodies launched by Chromatrap

Combatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Ixazomib’s phase 3 study in relapsed/refractory multiple myeloma presented

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News